Search Results - "Lengel, David"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Characterization of ascending dose canine telemetry model supports its use in E14/S7B QT integrated risk assessments by Chaves, Alysia A., Ferraro, Jude W., Yu, Jing, Moye, Matthew J., Yee, Ka Lai, Li, Fangbiao, Steve, Desiree L., Lengel, David J., Regan, Christopher P.

    “…Nonclinical evaluation of the cardiovascular effects of novel chemical or biological entities (NCE, NBEs) is crucial for supporting first-in-human clinical…”
    Get full text
    Journal Article
  2. 2

    An integrative pharmacological approach to radio telemetry and blood sampling in pharmaceutical drug discovery and safety assessment by Litwin, Dennis C, Lengel, David J, Kamendi, Harriet W, Bialecki, Russell A

    Published in Biomedical engineering online (18-01-2011)
    “…A successful integration of the automated blood sampling (ABS) and telemetry (ABST) system is described. The new ABST system facilitates concomitant collection…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Combining radio telemetry and automated blood sampling: A novel approach for integrative pharmacology and toxicology studies by Kamendi, Harriet W., Brott, David A., Chen, Yafei, Litwin, Dennis C., Lengel, David J., Fonck, Carlos, Bui, Khanh H., Gorko, Mary Ann, Bialecki, Russell A.

    “…A novel automated blood sampling and telemetry (ABST) system was developed to integrate pharmacokinetic (PK), pharmacodynamic (PD) and toxicology studies. The…”
    Get full text
    Journal Article
  6. 6

    Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors by Rumsey, W L, Aharony, D, Bialecki, R A, Abbott, B M, Barthlow, H G, Caccese, R, Ghanekar, S, Lengel, D, McCarthy, M, Wenrich, B, Undem, B, Ohnmacht, C, Shenvi, A, Albert, J S, Brown, F, Bernstein, P R, Russell, K

    “…The tachykinins, substance P, neurokinin A, and neurokinin B, have been implicated in many diseases. The present study evaluated the pharmacological properties…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Quantitative pharmacokinetic–pharmacodynamic modelling of baclofen‐mediated cardiovascular effects using BP and heart rate in rats by Kamendi, Harriet, Barthlow, Herbert, Lengel, David, Beaudoin, Marie‐Eve, Snow, Debra, Mettetal, Jerome T, Bialecki, Russell A

    Published in British journal of pharmacology (01-10-2016)
    “…Background and Purpose While the molecular pathways of baclofen toxicity are understood, the relationships between baclofen‐mediated perturbation of individual…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Assessment of cisplatin-induced kidney injury using an integrated rodent platform by Chen, Yafei, Brott, David, Luo, Wenli, Gangl, Eric, Kamendi, Harriet, Barthlow, Herbert, Lengel, David, Fikes, James, Kinter, Lewis, Valentin, Jean-Pierre, Bialecki, Russell

    Published in Toxicology and applied pharmacology (01-05-2013)
    “…Current diagnosis of drug-induced kidney injury (DIKI) primarily relies on detection of elevated plasma creatinine (Cr) or blood urea nitrogen (BUN) levels;…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Tachykinin-induced dyspnea in conscious guinea pigs by Kusner, E J, Buckner, C K, DeHaas, C J, Lengel, D J, Marks, R L, Krell, R D

    Published in European journal of pharmacology (21-01-1992)
    “…Aerosol administration of neurokinin A (NKA) or substance P (SP) to conscious guinea pigs produced labored abdominal breathing (dyspnea). Time to onset of…”
    Get more information
    Journal Article